Dr Mehdi Touat
- Spécialité
- Neuro-oncologue, expert tumeurs cérébrales primitives de l'adulte
- Hôpital
- Hôpital Pitié Salpétrière (Paris), APHP, Sorbonne Université, Institut du Cerveau
- Derniers articles
-
- Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data. (22 mai 2026)
- cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant Gliomas. (18 mai 2026)
- Brainstem tumours and invasive mechanical ventilation: Lessons from a single-centre cohort. (17 avr. 2026)
- Pembrolizumab monotherapy for microsatellite instability-high or mismatch repair deficient recurrent gliomas: results from the multicohort KEYNOTE-158 study. (1 avr. 2026)
- Preserved IDH mutation and methylation class in vorasidenib nonresponders: A report of 2 cases. (4 août 2025)